Barclays PLC (BACQ) discloses 6.90% beneficial stake in Bleichroeder
Filing Impact
Filing Sentiment
Form Type
SCHEDULE 13G
Rhea-AI Filing Summary
Barclays PLC reported beneficial ownership of 1,755,135 shares of Bleichroeder Acquisition Corp common stock, representing 6.90% of the class as of the event dated 12/31/2025. Barclays has sole voting and sole dispositive power over all these shares and no shared voting or dispositive power.
The position is reported on a Schedule 13G, indicating the securities were acquired and are held in the ordinary course of business, not for the purpose of changing or influencing control of the company. Subsidiaries identified in connection with this holding include Barclays Bank PLC and Barclays Capital Inc.
Positive
- None.
Negative
- None.
FAQ
Is Barclays PLC seeking control of BLEICHROEDER ACQUISITION COR with this 6.90% stake?
Barclays PLC states the BACQ shares were acquired and are held in the ordinary course of business. The filing specifies they were not acquired and are not held for changing or influencing control of BLEICHROEDER ACQUISITION COR.
What type of SEC filing did Barclays PLC submit for its BACQ ownership?
Barclays PLC submitted a Schedule 13G reporting its beneficial ownership in BLEICHROEDER ACQUISITION COR. Schedule 13G is typically used for passive investors holding more than 5% of a company’s registered equity securities.